Expanding the range of immunopathology in neuromyelitis optica spectrum disorder.

Abstract

Neuromyelitis optica (NMO) spectrum disorder typically associates with a pathognomonic antibody response directed against aquaporin 4 and a unique immunopathological signature characterised by loss of aquaporin 4 expression. We describe a tumefactive presentation of NMO in which a biopsy specimen demonstrated active demyelination and reactive astrocytes… (More)
DOI: 10.1136/bcr-2016-215981

Topics

Cite this paper

@article{Massey2016ExpandingTR, title={Expanding the range of immunopathology in neuromyelitis optica spectrum disorder.}, author={Jennifer J. Quinn Massey and Michael E Buckland and Yael Barnett and Ian J Sutton}, journal={BMJ case reports}, year={2016}, volume={2016} }